EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis

Ya Chen, Zongguang Tai iD, Congcong Zhu, Qin Yu, Quangang Zhu, Zhongjian Chen

International Journal of Molecular Sciences · 20.12.2023 · 25 (1) · 59

DOI: 10.3390/ijms25010059 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.12.2023. Verfasst von Ya Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Skin Disease Hospital, School of Medicine, Tongji University, 1278 Baode Road, Shanghai 200443, China. Hauptthemen laut MEDLINE: Psoriasis, Dermatitis. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Science and Technology Commission of Shanghai Municipality, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is an inflammatory skin disease mediated by the immune system and characterized by an inflammatory ring, also known as an epithelial immune microenvironment (EIME). The interaction between the epithelial tissue of the skin and the immune system has a crucial role in the immune cycle of psoriasis. Although the formation of new blood vessels in skin lesions provides energy support for the proliferation of epidermal keratinocytes, the role of angiogenesis in psoriasis has not been extensively studied. Vascular endothelial growth factor A (VEGFA) is a key regulator of angiogenesis that has an important role in the development of psoriasis. VEGFA promotes angiogenesis and directly stimulates epidermal keratinocytes and infiltrating immune cells, thus contributing to the progression of psoriasis. Measuring VEGFA levels to identify angiogenic characteristics in psoriasis patients may be a predictive biomarker for disease severity and response to anti-angiogenic therapy. Clinical data have shown that anti-angiogenic therapy can improve skin lesions in psoriasis patients. Therefore, this study aimed to uncover the underestimated role of blood vessels in psoriasis, explore the relationship between VEGFA and keratinocytes in the EIME, and inspire innovative drug therapies for the treatment of psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisDermatitisHumansVascular Endothelial Growth Factor ATreatment OutcomeSkin

Stichwörter der Autor:innen

angiogenesisepithelial immune microenvironmentpsoriasistherapeutic targetvascular endothelial growth factor A

Substanzen

Vascular Endothelial Growth Factor AVEGFA protein, human

Autor:innen und Institutionen

  • Shanghai Skin Disease Hospital, School of Medicine, Tongji University, 1278 Baode Road, Shanghai 200443, China.

ORCID-Profile: Zongguang Tai

Förderung

  • National Natural Science Foundation of China
  • the Science and Technology Commission of Shanghai Municipality
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Chen, Y., Tai, Z., Zhu, C., Yu, Q., Zhu, Q., & Chen, Z. (2023). Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis. International Journal of Molecular Sciences, 25(1), 59. https://doi.org/10.3390/ijms25010059

Vancouver

Chen Y, Tai Z, Zhu C, Yu Q, Zhu Q, Chen Z. Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis. International Journal of Molecular Sciences. 2023;25(1):59. doi:10.3390/ijms25010059

BibTeX
@article{Chen2023,
  author = {Chen, Ya and Tai, Zongguang and Zhu, Congcong and Yu, Qin and Zhu, Quangang and Chen, Zhongjian},
  title = {Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {25},
  number = {1},
  pages = {59},
  doi = {10.3390/ijms25010059}
}
Kostenlos starten →